BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28888027)

  • 1. Dermatopathic lymphadenopathy with Langerhans cell chimerism in graft-versus-host disease of the skin.
    Kreft A; Krümpelmann K; Rosenwald A; Hollemann D; Wagner-Drouet EM
    Eur J Haematol; 2017 Dec; 99(6):582-585. PubMed ID: 28888027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin of Langerhans cells in normal skin and chronic GVHD after hematopoietic stem-cell transplantation.
    Andani R; Robertson I; Macdonald KP; Durrant S; Hill GR; Khosrotehrani K
    Exp Dermatol; 2014 Jan; 23(1):75-7. PubMed ID: 24313654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic cutaneous graft-versus-host disease in children: A report of 14 patients from a tertiary care pediatric dermatology clinic.
    Nanda A; Husain MAA; Al-Herz W; Almekaimi A; Al-Sabah H; Al-Otaibi M
    Pediatr Dermatol; 2018 May; 35(3):343-353. PubMed ID: 29536565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous manifestations of graft-versus-host disease: role of the dermatologist.
    Kavand S; Lehman JS; Hashmi S; Gibson LE; El-Azhary RA
    Int J Dermatol; 2017 Feb; 56(2):131-140. PubMed ID: 27658806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease.
    Petersen SL; Madsen HO; Ryder LP; Svejgaard A; Masmas TN; Dickmeiss E; Heilmann C; Vindeløv LL
    Biol Blood Marrow Transplant; 2004 May; 10(5):337-46. PubMed ID: 15111933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute GVHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity conditioning allogeneic stem cell transplantation.
    El-Cheikh J; Vazquez A; Crocchiolo R; Furst S; Calmels B; Castagna L; Lemarie C; Granata A; Ladaique P; Oudin C; Faucher C; Chabannon C; Blaise D
    Am J Hematol; 2012 Dec; 87(12):1074-8. PubMed ID: 22911907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermoscopic Follow-Up of the Skin towards Acute Graft-versus-Host-Disease in Patients after Allogeneic Hematopoietic Stem Cell Transplantation.
    Kaminska-Winciorek G; Czerw T; Kruzel T; Giebel S
    Biomed Res Int; 2016; 2016():4535717. PubMed ID: 27446950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Features of cutaneous acute graft-versus-host disease by reflectance confocal microscopy.
    Saknite I; Gill M; Alessi-Fox C; Byrne M; Jagasia M; Gonzalez S; Ardigo M; Tkaczyk ER
    Br J Dermatol; 2019 Oct; 181(4):829-831. PubMed ID: 30927259
    [No Abstract]   [Full Text] [Related]  

  • 12. The fate of human Langerhans cells in hematopoietic stem cell transplantation.
    Collin MP; Hart DN; Jackson GH; Cook G; Cavet J; Mackinnon S; Middleton PG; Dickinson AM
    J Exp Med; 2006 Jan; 203(1):27-33. PubMed ID: 16390938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas.
    Bishop MR; Hou JW; Wilson WH; Steinberg SM; Odom J; Castro K; Kasten-Sportes C; Gea-Banacloche J; Marchigiani D; Gress R; Fowler DH
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):162-9. PubMed ID: 12652466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Kamble RT; Selby GB; Mims M; Kharfan-Dabaja MA; Ozer H; George JN
    Biol Blood Marrow Transplant; 2006 May; 12(5):506-10. PubMed ID: 16635785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial chimerism in chronic sclerotic-type chronic graft-versus-host disease (GVHD) and GVHD-associated angiomatosis.
    Kaffenberger BH; Zhang E; Duncan JR; Jaglowski S; Klisovic RB; Devine SM; Wong HK; Gru AA
    Br J Dermatol; 2016 Oct; 175(4):782-4. PubMed ID: 26875995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early-onset lichenoid graft-vs.-host disease: a unique variant of acute graft-vs.-host disease occurring in peripheral blood stem cell transplant recipients.
    Magro CM; Kerns MJ; Votava H; Vasil KE; Dyrsen ME; Morrison CD
    J Cutan Pathol; 2010 May; 37(5):549-58. PubMed ID: 19843195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
    Hirshfeld E; Weiss L; Kasir J; Zeira M; Slavin S; Shapira MY
    Bone Marrow Transplant; 2006 Sep; 38(5):359-64. PubMed ID: 16862165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease.
    Merad M; Hoffmann P; Ranheim E; Slaymaker S; Manz MG; Lira SA; Charo I; Cook DN; Weissman IL; Strober S; Engleman EG
    Nat Med; 2004 May; 10(5):510-7. PubMed ID: 15098028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor fibroblast chimerism in the pathogenic fibrotic lesion of human chronic graft-versus-host disease.
    Ogawa Y; Kodama H; Kameyama K; Yamazaki K; Yasuoka H; Okamoto S; Inoko H; Kawakami Y; Kuwana M
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4519-27. PubMed ID: 16303943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast appearance of donor dendritic cells in human skin: dynamics of skin and blood dendritic cells after allogeneic hematopoietic cell transplantation.
    Auffermann-Gretzinger S; Eger L; Bornhäuser M; Schäkel K; Oelschlaegel U; Schaich M; Illmer T; Thiede C; Ehninger G
    Transplantation; 2006 Mar; 81(6):866-73. PubMed ID: 16570010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.